IQVIA Holdings Inc.
General ticker "IQV" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $31.7B (TTM average)
IQVIA Holdings Inc. follows the US Stock Market performance with the rate: 61.4%.
Estimated limits based on current volatility of 1.8%: low 173.68$, high 180.13$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 88000 as of 2024
- North and South America accounted for 47.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Loss or delay of contracts, Underpricing/overpricing risks, Infrastructure disruption, Liability from services, Interest rate fluctuations
- Current price 12.4% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [203.75$, 284.81$]
- 2026-12-31 to 2027-12-31 estimated range: [219.14$, 304.69$]
Financial Metrics affecting the IQV estimates:
- Negative: with PPE of 18.8 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 14.02
- Positive: 6.64 < Operating cash flow per share per price, % of 6.87
- Positive: 19.40 < Shareholder equity ratio, % of 21.72 <= 42.68
- Positive: Inventory ratio change, % of -1.14 <= -0.75
- Positive: -14.22 < Investing cash flow per share per price, % of -5.97
Short-term IQV quotes
Long-term IQV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $14,984.00MM | $15,405.00MM | $16,310.00MM |
| Operating Expenses | $13,007.00MM | $13,203.00MM | $14,023.00MM |
| Operating Income | $1,977.00MM | $2,202.00MM | $2,287.00MM |
| Non-Operating Income | $-518.00MM | $-533.00MM | $-674.00MM |
| Interest Expense | $672.00MM | $670.00MM | $729.00MM |
| Income(Loss) | $1,459.00MM | $1,669.00MM | $1,613.00MM |
| Taxes | $101.00MM | $301.00MM | $252.00MM |
| Other Income(Loss) | $0.00MM | $5.00MM | $0.00MM |
| Profit(Loss)* | $1,358.00MM | $1,373.00MM | $1,360.00MM |
| Stockholders Equity | $6,112.00MM | $6,067.00MM | $6,503.00MM |
| Assets | $26,681.00MM | $26,899.00MM | $29,944.00MM |
| Operating Cash Flow | $2,149.00MM | $2,716.00MM | $2,654.00MM |
| Capital expenditure | $649.00MM | $602.00MM | $603.00MM |
| Investing Cash Flow | $-1,603.00MM | $-1,444.00MM | $-2,305.00MM |
| Financing Cash Flow | $-382.00MM | $-878.00MM | $-150.00MM |
| Earnings Per Share** | $7.39 | $7.57 | $7.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.